Sources | Names Used |
---|---|
GDSC1000, FIMM | Bexarotene |
CTRPv2 | bexarotene |
PharmacoGx | Bexarotene |
Database | Identifier |
---|---|
Smiles: | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
Inchikey: | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
Pubchem: | 82146 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HAL | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | MARK1 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-05 |
mRNA | CD44 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | CD33 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | DMXL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | CNTNAP5 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | SH3BGRL3 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | IL10RB | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-05 |
mRNA | ATP6V0E1 | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | NDUFAF5 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |